References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492.
- Tang J, Pearce L, O'Donnell-Tormey J, Hubbard-Lucey VM. Trends in the global immuno-oncology landscape. Nat Rev Drug Discov. 2018;17(11):783–784. doi:10.1038/nrd.2018.167.
- Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907–1918. doi:10.1016/S0140-6736(20)31187-9.
- Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894–901. doi:10.1016/j.annonc.2020.03.296.
- Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). [cited 2020 Jul 30]. Available from: https://www.who.int/publications-detail-redirect/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
- ESMO. Cancer Patient Management During the COVID-19 Pandemic. [cited 2020 Jul 16] Available from: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic
- Upadhaya S, Yu JX, Oliva C, Hooton M, Hodge J, Hubbard-Lucey VM. Impact of COVID-19 on oncology clinical trials. Nat Rev Drug Discov. 2020;19(6):376–377. doi:10.1038/d41573-020-00093-1.
- Waterhouse DM, Harvey RD, Hurley P, Levit LA, Kim ES, Klepin HD, et al. Early impact of COVID-19 on the conduct of oncology clinical trials and long-term opportunities for transformation: findings from an American Society of Clinical Oncology Survey. JCO Oncol Pract. 2020;16(7):417–421. doi:10.1200/OP.20.00275.
- Lundy JJ, Coons SJ, Aaronson NK. Testing the measurement equivalence of paper and interactive voice response system versions of the EORTC QLQ-C30. Qual Life Res. 2014;23(1):229–237. doi:10.1007/s11136-013-0454-1.
- Walle T, Erdal E, Muehlsteffen L, Singh HM, Gnutzmann E, Gruen B, et al. Feasibility and sociopsychological impact of video consultations in medical oncology – a randomized controlled open label trial. medRxiv. 2020. doi:10.1101/2020.07.10.20150052.
- Kitamura C, Zurawel-Balaura L, Wong RKS. How effective is video consultation in clinical oncology? A systematic review. Curr Oncol. 2010;17(3):17–27. doi:10.3747/co.v17i3.513.
- Taylor S, Bellhouse S, Allsop M, Radford J, Yorke J. The role of e-Health in the delivery of care for patients with hematological cancers: a systematic literature review. Telemed J EHealth. 2020;26(9):1093–1105. doi:10.1089/tmj.2019.0231.
- Janssen A, Brunner M, Keep M, Hines M, Nagarajan SV, Kielly-Carroll C, et al. Interdisciplinary eHealth practice in cancer care: a review of the literature. Int J Environ Res Public Health. 2017;25(11):14. doi:10.3390/ijerph14111289.
- Zhao X, Zhang B, Li P, Ma C, Gu J, Hou P, et al. Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis. medRxiv. 2020. doi:10.1101/2020.03.17.20037572.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72trun 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239. doi:10.1001/jama.2020.2648.
- Rosa C, Campbell ANC, Miele GM, Brunner M, Winstanley EL. Using e-technologies in clinical trials. Contemp Clin Trials. 2015;45(Pt A):41–54. doi:10.1016/j.cct.2015.07.007.